Perfecting Transfection

Transfection, the delivery of DNA into a eukaryotic cell, is now the standard methodology for studying gene expression and function. Scientists can transfect both primary cells--those derived directly from the body--and cultured cells, but primary cells are more accurate models of a given cell type than their cultured counterparts are. Researchers traditionally transfect primary cells using viral technologies, which can be expensive and complicated to use, but amaxa of Cologne, Germany, has deve

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

According to CEO and co-founder Rainer Christine, nucleofection is based on electroporation; a proprietary combination of electronic parameters and buffer solutions delivers DNA directly into the cell's nucleus. In contrast, traditional electroporation or lipofection techniques first deliver DNA into the cytoplasm, and nuclear import occurs only after the cell divides. The direct transfer of DNA not only enables non-dividing cells to be transfected, but also increases the speed of the assay for any cell type; whereas genes delivered using traditional transfection methods can take up to 72 hours to be expressed, nucleofected genes can be expressed within four to eight hours. "What we see is that gene expression starts very early. As soon as an hour after gene transfer you can see protein expression," says Christine.

Applications of Nucleofector technology include functional genomics, target validation, and lead generation. Christine also points out that the technology could facilitate gene therapy. "As ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies